Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.41 |
| ▸ | TSHR | P16473 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | WDR5 | P61964 | 1/20 | 0.40 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.40 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.40 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.39 |
| ▸ | HPRT1 | P00492 | 1/20 | 0.38 |
| ▸ | SOS1 | Q07889 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4852483 | 0.91 | HPRT1 (0.48) | MAPTHSD17B10TSHRALDH1A1CYP2A6 | |
| SCHEMBL4854059 | 0.87 | TSHR (0.39) | MAPTHSD17B10TSHRALDH1A1CYP2A6 | |
| SCHEMBL14452865 | 0.86 | CLK1 (0.43) | MAPTALDH1A1KDM4EGPR84ALOX5 | |
| SCHEMBL14452842 | 0.86 | CLK1 (0.43) | MAPTALDH1A1KDM4EGPR84ALOX5 | |
| SCHEMBL29716676 | 0.83 | TSHR (0.52) | MAPTHSD17B10TSHRALDH1A1CYP2A6 | |
| SCHEMBL868639 | 0.83 | TSHR (0.52) | MAPTHSD17B10TSHRALDH1A1CYP2A6 | |
| SCHEMBL867598 | 0.82 | DNMT1 (0.44) | MAPTHSD17B10TSHRALDH1A1CYP2A6 | |
| SCHEMBL29520144 | 0.82 | DNMT1 (0.44) | MAPTHSD17B10TSHRALDH1A1CYP2A6 | |
| SCHEMBL21385140 | 0.81 | TSHR (0.50) | MAPTHSD17B10TSHRALDH1A1CYP2A6 | |
| SCHEMBL19152708 | 0.79 | CA1 (0.48) | HSD17B10TSHRALDH1A1CYP2A6TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11555028-B2 | Organic compound and photoelectric conversion element | CANON KABUSHIKI KAISHA (JP) | 2023-01-17 | — | — | US | disclosed |
| US-20190119258-A1 | ORGANIC COMPOUND AND PHOTOELECTRIC CONVERSION ELEMENT | CANON KABUSHIKI KAISHA (JP) | 2019-04-25 | — | — | US | disclosed |
| US-7470290-B2 | Hydroscopic polymer gels for easier cleaning | THE CLOROX COMPANY (US) | 2008-12-30 | — | — | US | disclosed |
| US-7183010-B2 | Organic light-emitting diode devices with improved operational stability | EASTMAN KODAK CORPORATION (US) | 2007-02-27 | — | — | US | disclosed |
| US-20050245428-A1 | Hydroscopic polymer gels for easier cleaning | RODRIGUES KLIN A | 2005-11-03 | — | — | US | disclosed |
| US-20040076853-A1 | Organic light-emitting diode devices with improved operational stability | EASTMAN KODAK COMPANY | 2004-04-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190119258-A1 | ORGANIC COMPOUND AND PHOTOELECTRIC CONVERSION ELEMENT | SCN2B, MRPS22, CTNNA1 | MAPT 3956/4885HSD17B10 1632/4885TSHR 3018/4885 |
| US-11555028-B2 | Organic compound and photoelectric conversion element | SCN2B, MRPS22, CTNNA1 | MAPT 3956/4885HSD17B10 1632/4885TSHR 3018/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.